title: A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
authors.affiliation: University of Illinois, Chicago.
authors.forename: M Y
authors.initials: MY
authors.lastname: Dawood
authors.forename: W N
authors.initials: WN
authors.lastname: Spellacy
authors.forename: W P
authors.initials: WP
authors.lastname: Dmowski
authors.forename: R D
authors.initials: RD
authors.lastname: Gambrell
authors.forename: R B
authors.initials: RB
authors.lastname: Greenblatt
authors.forename: Y
authors.initials: Y
authors.lastname: Girard
authors.forename: A
authors.initials: A
authors.lastname: Lemay
authors.forename: D R
authors.initials: DR
authors.lastname: Mishell
authors.forename: M
authors.initials: M
authors.lastname: Nagamani
authors.forename: R J
authors.initials: RJ
authors.lastname: Pepperell
mesh_terms: D000328:Adult; D002064:Buserelin / Q000009:adverse effects / Q000627:therapeutic use*; D002979:Climacteric / Q000187:drug effects; D002985:Clinical Protocols; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use*; D004715:Endometriosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D004958:Estradiol / Q000097:blood; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D011245:Pregnadienes / Q000627:therapeutic use*; D012449:Safety
chemical_list: D011245:Pregnadienes; D004958:Estradiol; D003613:Danazol; D002064:Buserelin